Evercore ISI Starts Entrada Therapeutics (TRDA) at Outperform
Tweet
Share
E-mailGet Alerts TRDA Hot Sheet
Price: $7.46 +0.13%
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Evercore ISI analyst Jonathan Miller initiates coverage on Entrada Therapeutics (NASDAQ: TRDA) with a Outperform rating.
For an analyst ratings summary and ratings history on Entrada Therapeutics click here. For more ratings news on Entrada Therapeutics click here.
Shares of Entrada Therapeutics closed at $24.23 yesterday.
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- RBC Capital Starts Krystal Biotech (KRYS) at Outperform
- BMO Capital Resumes Snowline Gold Corp (SGD:CN) (SNWGF) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
